TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Andreas Glässner Marianne Eisenhardt Hans Dieter Nischalke Ulrich Spengler Tilman Sauerbruch Christian Körner Jacob Nattermann Benjamin Krämer Thomas Berg |
| Publication date | March 8, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |